Zhejiang Hisun Pharmaceutical Co., Ltd. (ZHEJIANG HISUN PHARMACEUTICAL C) Aktie
600267.SS
GeschlossenZHEJIANG HISUN PHARMACEUTICAL C
Market Cap
$11,448,169,472
Über Zhejiang Hisun Pharmaceutical Co., Ltd. (ZHEJIANG HISUN PHARMACEUTICAL C) Aktie
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.
Unternehmensinformationen
318000 Taizhou, China
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.